A series of tricyclic oxazines, namely, the 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, have been synthesized and assayed for dopamine agonist activity. One of the members of this series, compound (+)VII-15, was found to be a remarkably potent agonist in vivo when tested in the standard 6-hydroxydopamine lesioned rat assay. The absolute configuration of the compound corresponds to that found in the active isomer of apomorphine. Its activity at the alpha 2 receptor (vs. [3H]clonidine) is relatively low. It also failed to stimulate the synthesis of cAMP in the carp retina assay, thus giving the compound a highly selective profile in favor of the D2 receptor.
Experimental SectionMelting points were determined on a Mel-Temp apparatus and are uncorrected.NMR spectra were measured on Varían A-60A and JOEL FX-90Q NMR spectrometers. Optical rotations were measured on a Perkin-Elmer 241 polarimeter. Solvents were purified by standard methods. Diastereomeric oxaziridines 1-4 were prepared as previously described10 and were greater than 95 % ee. Sulfides were prepared by standard methods.Oxidative Kinetic Resolution Procedure. In a 5-mL, single-necked round-bottom flask equipped with magnetic stirring bar and drying tube was placed 0.8 mmol of the appropriate sulfoxide, 6a or 6b, in 1 mL of the designated solvent. The chiral oxaziridine, 0.4 mmol, was added as a solid portionwise with stirring to the reaction mixture. After 24 h of stirring at 25 °C, the solvent was removed under vacuum. The residue was taken up in a minimum of CHC13 and the sulfoxide isolated by preparative TLC (silica gel) using chloroform. Methyl p-tolyl sulfoxide (6a) required a second purification by TLC, developing with pentane-chloroform (1:1). Two-Step Kinetic Resolution Procedure. In a 10-mL, round-bottom flask equipped with a magnetic stirring bar and drying tube was placed 38 mg (0.27 mmol) of methyl p-tolyl sulfide (5a) in 1 mL of chloroform. The reaction mixture was cooled to -50 °C in a dry ice/methanol bath, and 132 mg (0.27 mmol) of oxaziridine (+)-(RJl)-4 in 1 mL of chloroform was added dropwise. After 1 h of stirring at room temperature, an additional 66 mg (0.135 mmol) of oxaziridine (+)-(Rfi)-4 was added. The reaction mixture was allowed to stir for 24 h, and methyl p-tolyl sulfoxide (6a) was isolated as described above. The optical purity of the sulfoxide, 11.4 mg (54%), was determined to be 27.9 % ee by using a chiral shift reagent.General Procedure for Determining Optical Purities of Sulfoxides. Optical yields were ascertained by comparing the optical rotations of sulfoxides 6a,b obtained via kinetic resolution using chiral 2-sulfonyloxaziridines 1, 3, and 4 with those reported in the literature.10 The optical yields determined in this manner were verified by comparing a series of 60-and 90-MHz 1 2H NMR spectra (CDC13) at increasing concentration of the chiral shift reagent tris [3 [(heptafluoropropyl)hydroxymethylene)]-d-camphorato]europium(III) derivative [Eu(hfc)3]. When the shift difference of the appropriate absorption was at least 9 Hz, the peak areas were determined by integration. Agreement between the two methods was approximately ±1.0 % ee.All asymmetric oxidations were carried out at least twice and the results averaged (Table I).Acknowledgment. Financial support from the National Science Foundation through Grant No. CHE-8114769 and Merck Sharp and Dohme are gratefully acknowledged. We thank a referee for constructive criticism.Registry No.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.